Welcome!

Microsoft Cloud Authors: Stackify Blog, Liz McMillan, David H Deans, Automic Blog, Pat Romanski

News Feed Item

Psychemedics Corporation Announces 3rd Quarter Earnings

Declares 65th Consecutive Quarterly Dividend

ACTON, Mass., Nov. 5, 2012 /PRNewswire/ -- Psychemedics Corporation (NASDAQ: PMD) today announced third quarter financial results for the period ended September 30, 2012.  The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of November 15, 2012 to be paid on November 28, 2012.  This will be the Company's 65th consecutive quarterly dividend.

(Logo: http://photos.prnewswire.com/prnh/20111107/NE00639LOGO )

The Company's revenue for the quarter ended September 30, 2012 was $6.5 million versus $6.3 million for the quarter ended September 30, 2011, an increase of 2%.  Net income for the quarter ended September 30, 2012 was $878 thousand or $0.17 per diluted share, versus $1.1 million or $0.21 per diluted share for the comparable period last year, a decrease of 20%. The Company's revenue for the nine months ended September 30, 2012 was $19.6 million, as compared to $18.5 million for the comparable period in 2011, an increase of 6%. Net income for the nine months ended September 30, 2012 was $2.7 million or $0.51 per diluted share, as compared to last year, during which the Company earned $3.1 million or $0.58 per diluted share, a decrease of 11%.

Raymond C. Kubacki, Chairman and Chief Executive Officer, said,

"I am happy to report what I believe was a very solid quarter for our Company, in view of the soft economy and the achievement of a major transition in our operations.

"While our revenue increased, it was below expectations, primarily due to a weak hiring environment lowering testing volume from our base business. However, new business accounted for all our growth including making up for lost volume on our base business. At the same time, we made a major transition in technology and operations, which we believe bodes well for our long-term growth, despite the cost impact on our quarter.

"This was a historic quarter for the Company.  During the quarter, we finalized development and put into production our new proprietary custom designed enzyme immunoassay (EIA) technology.  As you can imagine, this was not a small or inexpensive task.  This change required the re-engineering of several operational processes and systems.  While we absorbed one-time development costs, this is an important long-term investment for our Company. Meanwhile, our pre-tax margin for Q3 2012 exceeded 22%.

"As I reported on last quarter, the FDA granted the Company 501(k) clearances for five new, additional assays to test for the detection of cocaine, opiates, PCP, methamphetamine and marijuana using our custom designed EIA analysis of head and body hair. The newly developed immunoassays produced by the R&D team at Psychemedics were uniquely designed specifically to meet and even exceed the standards of radioimmunoassay, and represent a significant technological breakthrough.  By combining our new FDA-cleared immunoassays, which are equivalent in effectiveness and sensitivity to radioimmunoassay, with our new patented method of releasing the drugs from the hair, we continue to demonstrate our technological leadership and to offer truly proprietary technology that provides superior detection of drugs of abuse for our many clients.  That is what sets us apart.

"Another significant change implemented this quarter was the expansion of our laboratory capacity to include production on Saturdays. The primary purpose of this was to increase our customer service by allowing timelier reporting of test results to our clients. 

"We continue to have a strong balance sheet with $3.7 million in cash and cash equivalents as of September 30, 2012, despite making significant investments in equipment, and no long term debt. 

"Our directors share our confidence in the long-term future of Psychemedics and remain committed to rewarding shareholders and sharing the financial success of the Company with them as we move forward. 

"Therefore, the Board has declared a $0.15 dividend for the quarter. This is our 65th consecutive quarterly dividend."

Psychemedics is the world's largest provider of hair testing for drugs of abuse with thousands of corporations relying on the proprietary Psychemedics drug testing services.  Psychemedics' clients include over 10% of the Fortune 500, some of the largest police departments in America and nine Federal Reserve Banks.

The Psychemedics web site is www.psychemedics.com

Cautionary Statement for purposes of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995:  From time to time, information provided by Psychemedics may contain forward-looking information that involves risks and uncertainties.  In particular, statements contained in this release that are not historical facts (including but not limited to statements concerning earnings, earnings per share, revenues, dividends, future business, growth opportunities, new accounts, customer base, market share, test volume, sales and marketing strategies, technological changes, technological advantages, regulatory matters, and implementation of new testing procedures and processes) may be "forward looking" statements.  Actual results may differ from those stated in any forward-looking statements.  Factors that may cause such differences include but are not limited to risks associated with the expansion of the Company's sales and marketing team, development of markets for new products and services offered, implementation of new testing procedures and methodologies including training, personnel changes, changes in supplier relationships, customer contract provisions, customer relationships, the economic health of principal customers of the Company, government regulation, including but not limited to FDA regulations, competition and general economic conditions and other factors disclosed in the Company's filings with the Securities and Exchange Commission.

 

PSYCHEMEDICS CORPORATION

STATEMENTS OF INCOME

(UNAUDITED)

 







Three Months Ended



Nine Months Ended


September 30,



September 30,


2012


2011



2012


2011



















Revenues

$6,459,775


$6,315,142



$19,565,350


$18,542,666

Cost of revenues

2,742,072


2,371,255



8,079,141


7,243,474










Gross profit

3,717,703


3,943,887



11,486,209


11,299,192



















Operating Expenses:









   General & administrative

921,891


1,018,967



2,921,880


2,898,426

   Marketing & selling

1,067,768


981,197



3,413,388


2,945,492

   Research & development

297,090


136,281



679,031


399,785










Total Operating Expenses

2,286,749


2,136,445



7,014,299


6,243,703










Operating income

1,430,954


1,807,442



4,471,910


5,055,489

Interest income

447


773



1,442


4,790










Net income before provision for income taxes

1,431,401


1,808,215



4,473,352


5,060,279










Provision for income taxes

552,920


708,830



1,766,336


2,009,184










Net income and comprehensive income

$878,481


$1,099,385



$2,707,016


$3,051,095










Basic net income per share

$0.17


$0.21



$0.52


$0.58










Diluted net income per share

$0.17


$0.21



$0.51


$0.58










Dividends declared per share

$0.15


$0.12



$0.45


$0.36










Weighted average common shares outstanding, basic

5,272,428


5,237,603



5,256,240


5,227,699










Weighted average common shares outstanding, diluted

5,289,808


5,240,895



5,266,237


5,234,577











 

PSYCHEMEDICS CORPORATION

BALANCE SHEETS

(UNAUDITED)

 






September 30,


December 31,


2012


2011





ASSETS




 Current Assets:




   Cash and cash equivalents

$3,663,499


$5,564,233

   Accounts receivable, net of allowance for doubtful accounts




       of $131,218 in 2012 and $169,191 in 2011

5,343,338


4,490,976

   Prepaid expenses and other current assets

1,093,408


565,508

   Income tax receivable

--


564,083

   Deferred tax assets  

451,681


315,501





Total Current Assets

10,551,926


11,500,301

   Fixed Assets, net of accumulated amortization and depreciation




       of $4,222,467 in 2012 and $11,026,278 in 2011

3,490,382


2,063,377





   Other assets

309,717


237,174





Total Assets

$      14,352,025


$  13,800,852





LIABILITIES AND SHAREHOLDERS' EQUITY








Current Liabilities:




   Accounts payable

$1,266,603


$961,844

   Accrued expenses

984,465


1,321,856





Total Current Liabilities

2,251,068


2,283,700





   Deferred tax liabilities, long-term

482,523


482,523

Total Liabilities

2,733,591


2,766,223





Commitments and Contingencies




Shareholders' Equity:




   Preferred-stock, $0.005 par value, 872,521 shares authorized,




        no shares issued or outstanding

--


--

   Common stock, $0.005 par value; 50,000,000 shares authorized




       5,940,558 shares issued in 2012 and 5,903,552 shares issued 2011 

29,703


29,518

   Additional paid-in capital

28,338,280


28,095,946

   Accumulated deficit

(6,667,760)


(7,009,046)

   Less - Treasury stock, at cost, 668,130 shares

(10,081,789)


(10,081,789)





Total Shareholders' Equity

11,618,434


11,034,629





Total Liabilities and Shareholders' Equity

$14,352,025


$13,800,852









 

Contact:


Neil Lerner
Vice President of Finance
(978) 206-8220
[email protected]

SOURCE Psychemedics Corporation

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
The 20th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held June 6-8, 2017, at the Javits Center in New York City, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Containers, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportunity. Submit your speaking proposal ...
Grape Up is a software company, specialized in cloud native application development and professional services related to Cloud Foundry PaaS. With five expert teams that operate in various sectors of the market across the USA and Europe, we work with a variety of customers from emerging startups to Fortune 1000 companies.
Financial Technology has become a topic of intense interest throughout the cloud developer and enterprise IT communities. Accordingly, attendees at the upcoming 20th Cloud Expo at the Javits Center in New York, June 6-8, 2017, will find fresh new content in a new track called FinTech.
@GonzalezCarmen has been ranked the Number One Influencer and @ThingsExpo has been named the Number One Brand in the “M2M 2016: Top 100 Influencers and Brands” by Analytic. Onalytica analyzed tweets over the last 6 months mentioning the keywords M2M OR “Machine to Machine.” They then identified the top 100 most influential brands and individuals leading the discussion on Twitter.
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
Cognitive Computing is becoming the foundation for a new generation of solutions that have the potential to transform business. Unlike traditional approaches to building solutions, a cognitive computing approach allows the data to help determine the way applications are designed. This contrasts with conventional software development that begins with defining logic based on the current way a business operates. In her session at 18th Cloud Expo, Judith S. Hurwitz, President and CEO of Hurwitz & ...
SYS-CON Events announced today that Interoute, owner-operator of one of Europe's largest networks and a global cloud services platform, has been named “Bronze Sponsor” of SYS-CON's 20th Cloud Expo, which will take place on June 6-8, 2017 at the Javits Center in New York, New York. Interoute is the owner-operator of one of Europe's largest networks and a global cloud services platform which encompasses 12 data centers, 14 virtual data centers and 31 colocation centers, with connections to 195 add...
With billions of sensors deployed worldwide, the amount of machine-generated data will soon exceed what our networks can handle. But consumers and businesses will expect seamless experiences and real-time responsiveness. What does this mean for IoT devices and the infrastructure that supports them? More of the data will need to be handled at - or closer to - the devices themselves.
Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more business becomes digital the more stakeholders are interested in this data including how it relates to business. Some of these people have never used a monitoring tool before. They have a question on their mind like “How is my application doing” but no id...
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo 2016 in New York. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place June 6-8, 2017, at the Javits Center in New York City, New York, is co-located with 20th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry p...
Web Real-Time Communication APIs have quickly revolutionized what browsers are capable of. In addition to video and audio streams, we can now bi-directionally send arbitrary data over WebRTC's PeerConnection Data Channels. With the advent of Progressive Web Apps and new hardware APIs such as WebBluetooh and WebUSB, we can finally enable users to stitch together the Internet of Things directly from their browsers while communicating privately and securely in a decentralized way.
Multiple data types are pouring into IoT deployments. Data is coming in small packages as well as enormous files and data streams of many sizes. Widespread use of mobile devices adds to the total. In this power panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists will look at the tools and environments that are being put to use in IoT deployments, as well as the team skills a modern enterprise IT shop needs to keep things running, get a handle on all this data, and deli...
SYS-CON Events announced today that CollabNet, a global leader in enterprise software development, release automation and DevOps solutions, will be a Bronze Sponsor of SYS-CON's 20th International Cloud Expo®, taking place from June 6-8, 2017, at the Javits Center in New York City, NY. CollabNet offers a broad range of solutions with the mission of helping modern organizations deliver quality software at speed. The company’s latest innovation, the DevOps Lifecycle Manager (DLM), supports Value S...
The Internet of Things is clearly many things: data collection and analytics, wearables, Smart Grids and Smart Cities, the Industrial Internet, and more. Cool platforms like Arduino, Raspberry Pi, Intel's Galileo and Edison, and a diverse world of sensors are making the IoT a great toy box for developers in all these areas. In this Power Panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists discussed what things are the most important, which will have the most profound e...
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
SYS-CON Events announced today that Grape Up will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct. 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Grape Up is a software company specializing in cloud native application development and professional services related to Cloud Foundry PaaS. With five expert teams that operate in various sectors of the market across the U.S. and Europe, Grape Up works with a variety of customers from emergi...
The age of Digital Disruption is evolving into the next era – Digital Cohesion, an age in which applications securely self-assemble and deliver predictive services that continuously adapt to user behavior. Information from devices, sensors and applications around us will drive services seamlessly across mobile and fixed devices/infrastructure. This evolution is happening now in software defined services and secure networking. Four key drivers – Performance, Economics, Interoperability and Trust ...
@ThingsExpo has been named the Most Influential ‘Smart Cities - IIoT' Account and @BigDataExpo has been named fourteenth by Right Relevance (RR), which provides curated information and intelligence on approximately 50,000 topics. In addition, Right Relevance provides an Insights offering that combines the above Topics and Influencers information with real time conversations to provide actionable intelligence with visualizations to enable decision making. The Insights service is applicable to eve...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
Cybersecurity is a critical component of software development in many industries including medical devices. However, code is not always written to be robust or secure from the unknown or the unexpected. This gap can make medical devices susceptible to cybersecurity attacks ranging from compromised personal health information to life-sustaining treatment. In his session at @ThingsExpo, Clark Fortney, Software Engineer at Battelle, will discuss how programming oversight using key methods can incre...